logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation

Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.

date
18:42 07/09/2023
avatar
GMT Eight
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles
US Stock Market Move | Heart disease drug trial yields positive results, Cytokinetics (CYTK.US) surges over 20% in early trading.
PayPal accelerates AI deployment to drive cost reduction and efficiency improvement, planning to save $1.5 billion for reinvestment in growth.
CITYCHAMP (00256) proposed a "3 for 1" rights issue.
US Stock Market Move | Heart disease drug trial yields positive results, Cytokinetics (CYTK.US) surges over 20% in early trading.
PayPal accelerates AI deployment to drive cost reduction and efficiency improvement, planning to save $1.5 billion for reinvestment in growth.
CITYCHAMP (00256) proposed a "3 for 1" rights issue.
RECOMMEND
HKEX Signals Stronger Reforms While Upholding Listing Quality
HKEX Signals Stronger Reforms While Upholding Listing Quality
icon
02/05/2026
Retreat of Short Sellers Opens Valuation Window for Hong Kong’s AI Leaders
Retreat of Short Sellers Opens Valuation Window for Hong Kong’s AI Leaders
icon
02/05/2026
Explosive Token Growth Signals New Stage for China’s AI
Explosive Token Growth Signals New Stage for China’s AI
icon
02/05/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.